VANI — Vivani Medical Share News
0.000.00%
Last trade - 00:00Vivani Medical rises after appointing former Amylin Pharmaceuticals CEO to its board
Brief: Vivani Medical Appoints Daniel Bradbury To Board
Brief: Vivani Medical Appoints Daniel Bradbury To Its Board
Brief: Vivani Medical Announces Pricing Of $15.0 Million Registered Direct Offering Of Common Stock And Warrants
U.S. STOCKS ON THE MOVE-Shift4 Payments, Chart Industries, Applied Therapeutics
U.S. STOCKS ON THE MOVE-Permian Resources, Vivani, Incannex
Vivani shares skyrocket as implant reduces weight in mice
Vivani soars on positive preclinical data from weight-loss trial
Brief: Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data
Brief: Vivani Medical Says Co Received Letter From Nasdaq Stating It Had Regained Compliance With Nasdaq Listing Rule 5550(A)(2)
Brief: Vivani Medical Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Vivani Medical Inc - On August 11, FDA Provided Verbal Notice That Liberate-1 Study Was Placed On Clinical Hold
Vivani Medical Inc expected to post a loss of 11 cents a share - Earnings Preview
Brief: Vivani Medical Reports First Quarter Financial Results And Provides Business Update
Brief: Joachim Bolck Reports 11.03% Stake In Vivani Medical Inc - SEC Filing
Brief: Vivani Medical Announces $1 Million NIH Grant Funding
Brief: Vivani Medical Announces Public Filing Of Registration Statement For The Proposed IPO Of Cortigent Inc
Brief: Vivani Medical Says On Dec 9, 2022, Co Received Notice That Paris Commercial Court Rendered Its Judgement, Finding Co's Termination Of MoU Was Not Valid
Brief: Vivani Medical Inc Says Estimate Cash Resources Are Sufficient To Fund Planned Operations Into Second Half Of 2024